At a recent meeting in Boston, representatives from global pharmaceutical companies gathered to discuss how to transition from batch to continuous manufacturing. And what company better to learn from ...

Transform the production of oral solid dosage forms in the pharmaceutical industry with L.B. Bohle. L.B. Bohle supports companies with their machines and processes in adopting Continuous Manufacturing ...

Enzene’s New Jersey facility offers efficient, fully continuous or hybrid vat production within a modular framework.

A handful of companies have done pioneering work with continuous manufacturing, the production process that is faster, cheaper and less prone to the kinds of manufacturing mess-ups that worry the FDA.

Continuous manufacturing makes monoclonal antibody production faster, cheaper, and greener, say researchers, who predict that industry adoption of the approach will accelerate in response to ...

The pharmaceutical industry has been slow to adopt a business practice that is faster, safer, and more efficient than its current way of operating; that the FDA has been encouraging the industry to ...

Industry groups have identified upfront costs as a barrier to streamlining U.S. drugmaking. The nonprofit API Innovation Center has a proposed answer for how to tilt finances in favor of investments ...

In November 2016, Continuus Pharmaceuticals was awarded a $4.4 million contract by the U.S. Food and Drug Administration (FDA). The partnership revolves around a pilot project that will result in a ...

Continued process verification (CPV) is the third stage of the product lifecycle of any medicine either within the small or large molecule arena. The CPV is the subsequent step to process design ...

DIANT is a startup co-founded by Antonio Costa, Ph.D. and Diane Burgess, Ph.D. In 2020, DIANT licensed their core manufacturing technology from UConn and was granted a patent on the technology earlier ...

The company Debut Bio has announced their seed funding of $2.6 million, with KdT Ventures leading. The round was oversubscribed and included participation from Better Ventures, FTW Ventures, and ...